Stock Taper Total Revenue: $25.9 million, a 73% increase year-over-year, primarily due to the acquisition of Irwin Naturals.
Wholesale Revenue: $15.5 million (60% of total revenue), up 213% year-over-year.
Online Revenue: $10.5 million (40% of total revenue), a 4% increase year-over-year.
Gross Margin: 37.0%, down from 41.4% in Q4 2024, largely due to the lower margins associated with Irwin.
Net Income: $1.6 million, down from $2.1 million in Q4 2024, impacted by transaction-related expenses.
Adjusted EBITDA: $3.5 million, a 14% increase year-over-year.
Legacy FitLife Revenue: $13.3 million, a 12% decrease year-over-year, with declines in both wholesale (14%) and online (10%) channels.
Irwin Naturals Acquisition: This was the first full quarter of Irwin's financial results post-acquisition. Irwin delivered organic growth of approximately 6% in Q4 2025 compared to Q4 2024.
Supply Chain Improvements: Plans to transition Irwin products to a 3-year shelf life to reduce inventory obsolescence, which could enhance gross margins significantly.
Product Development: Focus on launching new products at Irwin, with three new products expected in Q3 2026.
Marketing Initiatives: Increased emphasis on off-Amazon marketing strategies, including partnerships with influencers and social media advertising.
2026 Outlook: No formal guidance provided due to ongoing uncertainties and challenges in the market. The company is cautious about the potential for revenue growth, especially given the weak performance in Q1 2026.
Debt Reduction: Continued efforts to pay down debt, with $1.9 million paid down in Q4 2025.
Weakness in Legacy FitLife Brands: Significant declines in revenue from MRC and MusclePharm, contributing to overall revenue drop in legacy brands.
Consumer Sentiment: Broader economic and political volatility affecting consumer confidence and discretionary spending.
Amazon Challenges: Declines in subscriber counts across most brands on Amazon, attributed to changes in Amazon's algorithm affecting traffic and conversions.
Irwin's Customer Losses: Loss of major customers such as Costco U.S. and Rite Aid, complicating revenue recovery efforts.
Revenue Headwinds: CEO Dayton Judd indicated difficulty in separating the impacts of macroeconomic pressures versus specific brand challenges, noting that overall consumer spending has been declining.
Gross Margin Expectations: Judd suggested that while Irwin's margins may improve, reaching the historical levels of legacy FitLife brands (around 40%) may be challenging.
MusclePharm's Recovery: Judd acknowledged the difficulties in revitalizing MusclePharm, emphasizing the need for realistic expectations regarding its growth potential.
Inventory Management: Discussion on the complexities of transitioning to a 3-year shelf life for products, which is expected to take time but could significantly reduce inventory write-offs. Overall, while FitLife Brands has seen growth from its acquisition of Irwin, it faces significant challenges in its legacy brands and broader market conditions, leading to a cautious outlook for 2026.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT